Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- OTC NEWS IN BRIEF
October 15, 2001
- Switch to Materials from BSE-free Countries Considered by Makers
October 15, 2001
- Cooperation of Medical Institutions Essential for Immediate PMS
October 15, 2001
- Medical Professionals Asked For Cooperation with Immediate PMS
October 15, 2001
- Gastric Cancer Closely Linked with H. pylori Infection: Seminar
October 8, 2001
- Bill for Healthcare Reform to Be Presented to Diet Next Year -1-
October 8, 2001
- Losartan Shows Renal Protective Effects: NEJM
October 8, 2001
- WORLD NEWS IN BRIEF
October 8, 2001
- AIST, Toyo Shinyaku to Screen Plant Extracts That Kill Leukemia Cells
October 8, 2001
- Bill for Healthcare Reform to Be Presented to Diet Next Year -3-
October 8, 2001
- JPMA, ABPI Deepen R&D Exchanges
October 8, 2001
- Bill for Healthcare Reform to Be Presented to Diet Next Year -4-
October 8, 2001
- DIAGNOSTIC NEWS IN BRIEF
October 8, 2001
- Dr Kurokawa Explains Background for Proposed PAL Amendment
October 8, 2001
- JMA, Hospital Associations Confirm Opposition to Operation of Hospitals by Private Companies
October 8, 2001
- REGULATORY NEWS IN BRIEF
October 8, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 8, 2001
- Organon Focuses on Strengthening R&D in Japan: President-elect Vemer
October 8, 2001
- OTC NEWS IN BRIEF
October 8, 2001
- Mitsubishi Pharma Corp Starts Operation
October 8, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…